ArticleMolecular psychiatry2025
Aberrant personal space is associated with paranoia, altered stress regulation, and unfavourable outcomes at 6 months' follow-up in schizophrenia.
Article in Molecular psychiatry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Social interactions in isolated, confined, and extreme environments: A study of Antarctic winter teams using wearable sensors.Proceedings of the National Academy of Sciences of the United States of America · 2026Article
- I fear you're getting too close: neural correlates of personal space violation in paranoia.Schizophrenia (Heidelberg, Germany) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Paranoia is a central feature of schizophrenia and linked with poor outcomes. Paranoid experience is sometimes hard to identify in the clinical interview. In contrast, personal space (PS) measures detected patients with paranoia with excellent sensitivity and specificity. Here we test whether we can substantiate aberrant PS regulation in paranoia and whether PS was associated with stress markers and longitudinal outcomes. We included 144 participants (92 patients with schizophrenia spectrum disorders and 52 age and sex-matched healthy controls). We measured PS and stress markers during two behavioural tasks on interpersonal distance. In addition, we assessed social outcomes at baseline and after 6 months. Data corroborated that paranoia increased PS. Moreover, we confirmed that PS detected paranoia with excellent sensitivity (92%) at 1.1 m, and severe paranoia with 87% sensitivity and 81% specificity at 1.6 m. In addition, stress (Electrodermal activity) during the PS task was associated with paranoia and PS. Furthermore, higher stress at baseline predicted less improvement of social outcome after 6 months. Finally, improvement of PS over 6 months was associated with improvement of social functioning. PS may indeed serve as a simple bedside test for paranoia. Furthermore, results have direct implications in clinical practice as they suggest that it is advisable to maintain increased PS with paranoid patients. In addition, altered stress regulation and persistently increased PS may indicate unfavourable outcomes in the short-term follow-up. Thus, patients with persistently increased PS may benefit from special therapeutic attention.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.